Treatment Patterns and Clinical Outcomes Among Patients with ...

Treatment Patterns and Clinical Outcomes Among Patients With ...

Treatment patterns identified in this study were similar to those among patients with mCRPC regardless of tumor HRR mutation status in the literature.

Treatment patterns and clinical outcomes among patients ... - PubMed

This study used the ConcertAI Oncology Dataset to assess treatment patterns, real-world progression-free survival (rwPFS), and real-world overall survival ( ...

Treatment patterns and clinical outcomes among patients with biliary ...

398Background: The American Cancer Society estimates 11980 new cases of biliary tract cancers (BTCs), including gall bladder and nearby ...

Treatment Patterns and Clinical Outcomes Among Patients with ...

We aimed to assess treatment patterns and clinical outcomes among patients with metastatic non-small cell lung cancer, no actionable genomic alterations,

Treatment Patterns and Clinical Outcomes in Patients With EGFR ...

1. ... The first-line treatment for patients with EGFR-mutant lung cancer is likely to evolve over the coming years, as recent data have ...

Treatment Patterns and Clinical Outcomes Among Patients With ...

The current chart review study was conducted to describe the treatment patterns and clinical outcomes observed among patients with mCRPC harboring somatic HRR ...

advanced/metastatic breast cancer receiving palbociclib in Brazil ...

Real-world treatment patterns and clinical outcomes among patients with HR+/HER2- advanced/metastatic breast cancer receiving palbociclib in ...

Real-World Clinical Outcomes and Treatment Patterns Among Black ...

By Benjamin H. Lowentritt, Carmine Rossi & 6 more. This study describes real-world treatment patterns and clinical outcomes among patients ...

Real-world treatment patterns and clinical outcomes among patients ...

This large-scale, US-based study characterized real-world treatment patterns and clinical outcomes in patients with advanced or metastatic urothelial carcinoma ...

Treatment Patterns and Clinical Outcomes Among Metastatic Non ...

Most patients are diagnosed with metastatic non–small-cell lung cancer (mNSCLC), and treatment is largely palliative. The estimated 5-year survival for patients ...

Abstract 6754: Clinical characteristics, real-world treatment patterns ...

Abstract 6754: Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic ...

Treatment patterns and clinical outcomes among patients <65 years ...

The aim of this study was to evaluate treatment patterns and clinical outcomes in commercially insured chronic HFrEF patients <65 years old during 1-year ...

Real-World Treatment Patterns and Clinical Outcomes Among ...

Baseline clinical characteristics that were collected included the patients' RCC tumor histology Memorial Sloan Kettering Cancer Center risk ...

Treatment Patterns and Health Outcomes among Patients with ...

This study describes real-world evidence on treatment patterns and outcomes for a population-based cohort of patients with human epidermal growth factor ...

Real-World Treatment Patterns and Clinical Outcomes Among ...

For patients with epidermal growth factor receptor-mutated (EGFRm) locally advanced/metastatic non-small cell lung cancer (mNSCLC) whose ...

Real-World Treatment Patterns and Clinical Outcomes in Patients ...

Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC: results of KINDLE, a multicountry observational study.

935P Demographics, clinical characteristics, treatment patterns and ...

This retrospective study describes demographics, clinical characteristics, treatment (Tx) patterns and clinical outcomes of resected patients (pts) diagnosed ...

Treatment Patterns and Outcomes Among Patients with Relapsed ...

Exclusion criteria included: evidence of clinical trial participation during the study period, high-grade (3b) FL at diagnosis, transformation ...

Real-world treatment patterns and clinical outcomes among patients ...

BACKGROUND: Nearly 30% of new renal cell carcinoma (RCC) cases are diagnosed at an advanced or metastatic stage. Recent approvals of immunotherapies (IO) ...

A retrospective chart review of drug treatment patterns and clinical ...

A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue ...